Synchrony Financial SYF
NYSE · United States · Finance
$70.97-0.75 (-1.05%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Synchrony Financial (SYF) drew fresh attention after CareCredit, its healthcare financing arm, agreed to embed payment options directly into Vetspire’s AI veterinary platform, linking consumer credit with real time pet care decisions. The recent Vetspire deal lands at a tricky moment for the stock, with the share price down 15.27% year to date and 8.11% over the past month. At the same time, Synchrony Financial’s 3-year total shareholder return of about 162% signals long-run momentum that...
Recently, CareCredit, part of Synchrony Financial, announced a partnership with Vetspire to embed CareCredit financing into Vetspire’s AI-enabled veterinary practice management platform, while Synchrony also released its 2026 AI in Commerce study with Oxford Economics highlighting consumer priorities around security, transparency, and fraud protection in AI-driven shopping. Together, these moves underline Synchrony’s push to embed financing directly into specialized healthcare workflows and...
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Synchrony Financial is poised to release its third-quarter results next month, and analysts are projecting a double-digit earnings decrease.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.